Nevertheless, many other studies have revealed that individuals with NSCLC carrying 19‐Del and 21‐L858R mutations can have two separate diseases with differing underlying sensitivities to EGFR‐TKIs. This evidence concerns the gene EGFR and non-small cell lung carcinoma.